2019 JPS临床实践指南:胰腺癌(概要)

2020-03-20 日本胰脏学会 Pancreas . 2020 Mar;49(3):326-335.

日本胰腺学会《胰腺癌临床实践指南》(简称指南)初版发表于2006 年,后于2009 年、2013 年、2016 年分别进行了形式与内容的更新,近期再予更新,保持每3~4 年更新1次的频率。2019 年

中文标题:

2019 JPS临床实践指南:胰腺癌(概要)

英文标题:

Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A Synopsis

发布机构:

日本胰脏学会

发布日期:

2020-03-20

简要介绍:

日本胰腺学会《胰腺癌临床实践指南》(简称指南)初版发表于2006 年,后于2009 年、2013 年、2016 年分别进行了形式与内容的更新,近期再予更新,保持每3~4 年更新1次的频率。2019 年版指南继续沿革既往以问题为导向、以循证为基础的修订原则,结合近年来胰腺癌诊治进展,在多学科诊治、新辅助治疗指征及方案选择、腹腔镜胰十二指肠切除术、姑息治疗、术后放化疗等方面进行了更新。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2019 JPS临床实践指南:胰腺癌(概要).pdf)] GetToolGuiderByIdResponse(projectId=1, id=150161c001999178, title=2019 JPS临床实践指南:胰腺癌(概要), enTitle=Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A Synopsis, guiderFrom=Pancreas . 2020 Mar;49(3):326-335., authorId=0, author=, summary=日本胰腺学会《胰腺癌临床实践指南》(简称指南)初版发表于2006 年,后于2009 年、2013 年、2016 年分别进行了形式与内容的更新,近期再予更新,保持每3~4 年更新1次的频率。2019 年, cover=https://img.medsci.cn/20201029/1603982681606_2020535.jpg, journalId=0, articlesId=null, associationId=1002, associationName=日本胰脏学会, associationIntro=null, copyright=0, guiderPublishedTime=Fri Mar 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>日本胰腺学会《胰腺癌临床实践指南》(简称指南)初版发表于2006 年,后于2009 年、2013 年、2016 年分别进行了形式与内容的更新,近期再予更新,保持每3~4 年更新1次的频率。2019 年版指南继续沿革既往以问题为导向、以循证为基础的修订原则,结合近年来胰腺癌诊治进展,在多学科诊治、新辅助治疗指征及方案选择、腹腔镜胰十二指肠切除术、姑息治疗、术后放化疗等方面进行了更新。</p> </div> </div> </div>, tagList=[TagDto(tagId=718, tagName=胰腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=718, guiderKeyword=胰腺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2235, appHits=139, showAppHits=0, pcHits=483, showPcHits=2096, likes=1, shares=7, comments=14, approvalStatus=1, publishedTime=Thu Oct 29 23:24:31 CST 2020, publishedTimeString=2020-03-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Oct 29 22:44:47 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 00:09:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2019 JPS临床实践指南:胰腺癌(概要).pdf)])
2019 JPS临床实践指南:胰腺癌(概要).pdf
下载请点击:
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1180993, encodeId=17981180993a3, content=认真学习,收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c135726045, createdName=ms3000001599502875, createdTime=Wed Jan 05 19:38:57 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062517, encodeId=4635106251e55, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Thu Oct 21 09:53:34 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001348, encodeId=4d2e100134821, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ec5456575, createdName=ms5000001852640370, createdTime=Wed Jul 21 10:07:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967210, encodeId=35cf96e21093, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210520/04ad8cce999b47239bc9e83fac65f115/416372675e94449a87ec6c88857d0a6c.jpg, createdBy=e2995505132, createdName=polipapa, createdTime=Thu May 20 13:18:06 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954244, encodeId=a7cf954244a1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8dff5409957, createdName=ms8000000268807725, createdTime=Tue Apr 06 16:52:27 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2022-01-05 ms3000001599502875

    认真学习,收藏

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1180993, encodeId=17981180993a3, content=认真学习,收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c135726045, createdName=ms3000001599502875, createdTime=Wed Jan 05 19:38:57 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062517, encodeId=4635106251e55, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Thu Oct 21 09:53:34 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001348, encodeId=4d2e100134821, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ec5456575, createdName=ms5000001852640370, createdTime=Wed Jul 21 10:07:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967210, encodeId=35cf96e21093, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210520/04ad8cce999b47239bc9e83fac65f115/416372675e94449a87ec6c88857d0a6c.jpg, createdBy=e2995505132, createdName=polipapa, createdTime=Thu May 20 13:18:06 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954244, encodeId=a7cf954244a1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8dff5409957, createdName=ms8000000268807725, createdTime=Tue Apr 06 16:52:27 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-10-21 ms8000001549818402

    谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1180993, encodeId=17981180993a3, content=认真学习,收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c135726045, createdName=ms3000001599502875, createdTime=Wed Jan 05 19:38:57 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062517, encodeId=4635106251e55, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Thu Oct 21 09:53:34 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001348, encodeId=4d2e100134821, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ec5456575, createdName=ms5000001852640370, createdTime=Wed Jul 21 10:07:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967210, encodeId=35cf96e21093, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210520/04ad8cce999b47239bc9e83fac65f115/416372675e94449a87ec6c88857d0a6c.jpg, createdBy=e2995505132, createdName=polipapa, createdTime=Thu May 20 13:18:06 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954244, encodeId=a7cf954244a1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8dff5409957, createdName=ms8000000268807725, createdTime=Tue Apr 06 16:52:27 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-07-21 ms5000001852640370

    可以

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1180993, encodeId=17981180993a3, content=认真学习,收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c135726045, createdName=ms3000001599502875, createdTime=Wed Jan 05 19:38:57 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062517, encodeId=4635106251e55, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Thu Oct 21 09:53:34 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001348, encodeId=4d2e100134821, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ec5456575, createdName=ms5000001852640370, createdTime=Wed Jul 21 10:07:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967210, encodeId=35cf96e21093, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210520/04ad8cce999b47239bc9e83fac65f115/416372675e94449a87ec6c88857d0a6c.jpg, createdBy=e2995505132, createdName=polipapa, createdTime=Thu May 20 13:18:06 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954244, encodeId=a7cf954244a1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8dff5409957, createdName=ms8000000268807725, createdTime=Tue Apr 06 16:52:27 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-05-20 polipapa

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1180993, encodeId=17981180993a3, content=认真学习,收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c135726045, createdName=ms3000001599502875, createdTime=Wed Jan 05 19:38:57 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062517, encodeId=4635106251e55, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Thu Oct 21 09:53:34 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001348, encodeId=4d2e100134821, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ec5456575, createdName=ms5000001852640370, createdTime=Wed Jul 21 10:07:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967210, encodeId=35cf96e21093, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210520/04ad8cce999b47239bc9e83fac65f115/416372675e94449a87ec6c88857d0a6c.jpg, createdBy=e2995505132, createdName=polipapa, createdTime=Thu May 20 13:18:06 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954244, encodeId=a7cf954244a1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8dff5409957, createdName=ms8000000268807725, createdTime=Tue Apr 06 16:52:27 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-04-06 ms8000000268807725

    谢谢

    0